Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WRG
|
|||
| Former ID |
DIB009754
|
|||
| Drug Name |
CEP-41750
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 3 | [1] | |
| Company |
Teva pharmaceutical; mesoblast
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02032004) The Purpose of This Study is to Evaluate the Efficacy and Safety of a Allogeneic Mesenchymal Precursor Cells (CEP-41750) for the Treatment of Chronic Heart Failure.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.